e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
How do different treatment strategies translate into costs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Publication rate and characteristics of industry-sponsored asthma clinical trials
S. Khanolkar (Airoli, India), R. Thale (Airoli, India), M. Bolshete (Airoli, India), V. Jakhetia (Airoli, India), P. Bolshete (Airoli, India)
Source:
Virtual Congress 2020 – How do different treatment strategies translate into costs
Session:
How do different treatment strategies translate into costs
Session type:
Oral Presentation
Number:
4815
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Khanolkar (Airoli, India), R. Thale (Airoli, India), M. Bolshete (Airoli, India), V. Jakhetia (Airoli, India), P. Bolshete (Airoli, India). Publication rate and characteristics of industry-sponsored asthma clinical trials. 4815
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001
Current clinical trials
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019
Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006
Safety of formoterol in asthma clinical trials: an update
Source: Eur Respir J 2014; 43: 103-114
Year: 2004
Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection.
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018
Patient perspective of participation in COVID-19 clinical trials
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021
Clinical trials and outcome measures
Source: School Course 2013 - Primary ciliary dyskinesia: sharing knowledge and experience across Europe
Year: 2013
Emerging concepts in outcome assessment for COPD clinical trials
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007
Clinical trials design in the age of precision medicine
Source: ERS webinar 2020: Clinical trials design in the age of precision medicine
Year: 2020
Clinical effectiveness of MDI-HFA-Modulite beclomethasone in the treatment of asthma – meta-analysis of randomized controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006
Preschool asthma - have randomised controlled trials provided clarity on management?
Source: International Congress 2018 – Infectious agents and childhood asthma
Year: 2018
Safety of formoterol in asthma clinical trials
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012
Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD
Source: International Congress 2017 – Management of COPD
Year: 2017
Seasonal pattern of exacerbation rates in the tiotropium clinical trial database
Source: Eur Respir J 2007; 30: Suppl. 51, 609s
Year: 2007
Run-in bias in randomised trials: the case of COPD medications
Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017
Year: 2017
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019
Year: 2019
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
Source: Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept